Hanna Nylén

494 total citations
12 papers, 423 citations indexed

About

Hanna Nylén is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Hanna Nylén has authored 12 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Hanna Nylén's work include Cholesterol and Lipid Metabolism (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Hanna Nylén is often cited by papers focused on Cholesterol and Lipid Metabolism (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Hanna Nylén collaborates with scholars based in Sweden, Ethiopia and Germany. Hanna Nylén's co-authors include Ulf Diczfalusy, Leif Bertilsson, Linda Björkhem‐Bergman, Yuko Rönquist-Nii, Tobias Bäckström, Tommy B. Andersson, Eva Bredberg, Katarina Wide, Eleni Aklillu and Anita Lövgren‐Sandblom and has published in prestigious journals such as Medicine, British Journal of Clinical Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

Hanna Nylén

12 papers receiving 420 citations

Peers

Hanna Nylén

PHARM

ONCOL

EDM

SURGE

Andreas K. Nuessler Germany

Rame Khasawneh Jordan

Gurusamy Umamaheswaran India

Carl Guévin Canada

Hyun-Jung Cho South Korea

Dhanashri Kolwankar United States

Ron van Schaik Netherlands

P. Neuhaus Germany

Christine Reynolds United States

Caroline Moreau France

Andreas K. Nuessler Germany

Hanna Nylén

189 ×0.8

PHARM

184 ×1.4

ONCOL

32 ×0.3

EDM

98 ×0.9

SURGE

118 ×1.5

Citations per year, relative to Hanna Nylén Hanna Nylén (= 1×) peers Andreas K. Nuessler

Countries citing papers authored by Hanna Nylén

Since Specialization

Citations

This map shows the geographic impact of Hanna Nylén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna Nylén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna Nylén more than expected).

Fields of papers citing papers by Hanna Nylén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanna Nylén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna Nylén. The network helps show where Hanna Nylén may publish in the future.

Co-authorship network of co-authors of Hanna Nylén

This figure shows the co-authorship network connecting the top 25 collaborators of Hanna Nylén. A scholar is included among the top collaborators of Hanna Nylén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanna Nylén. Hanna Nylén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Nylén, Hanna, Abiy Habtewold, Eyasu Makonnen, et al.. (2017). PREVALENCE AND RISK FACTORS FOR EFAVIRENZ-BASED ANTIRETROVIRAL TREATMENT-ASSOCIATED SEVERE VITAMIN D DEFICIENCY: A PROSPECTIVE COHORT STUDY. BMJ Global Health. 2(Suppl 2). A11.1–A11. 4 indexed citations

Nylén, Hanna, Abiy Habtewold, Eyasu Makonnen, et al.. (2016). Prevalence and risk factors for efavirenz-based antiretroviral treatment–associated severe vitamin D deficiency. Medicine. 95(34). e4631–e4631. 13 indexed citations

Björkhem‐Bergman, Linda, Hanna Nylén, Mats Eriksson, Paolo Parini, & Ulf Diczfalusy. (2015). Effect of Statin Treatment on Plasma 4β‐Hydroxycholesterol Concentrations. Basic & Clinical Pharmacology & Toxicology. 118(6). 499–502. 10 indexed citations

Ekström, Lena, Marie‐Louise Ovesjö, Eleni Aklillu, et al.. (2015). miRNA‐27b levels are associated with CYP3A activity in vitro and in vivo. Pharmacology Research & Perspectives. 3(6). e00192–e00192. 20 indexed citations

Björkhem‐Bergman, Linda, Tobias Bäckström, Hanna Nylén, et al.. (2014). Quinine Compared to 4β-Hydroxycholesterol and Midazolam as Markers for CYP3A Induction by Rifampicin. Drug Metabolism and Pharmacokinetics. 29(4). 352–355. 18 indexed citations

Nylén, Hanna, Linda Björkhem‐Bergman, Lena Ekström, et al.. (2014). Plasma Levels of 25‐Hydroxyvitamin D₃ and In Vivo Markers of Cytochrome P450 3A Activity in Swedes and Koreans: Effects of a Genetic Polymorphism and Oral Contraceptives. Basic & Clinical Pharmacology & Toxicology. 115(4). 366–371. 8 indexed citations

Björkhem‐Bergman, Linda, Hanna Nylén, Anna-Carin Norlin, et al.. (2013). Serum Levels of 25-Hydroxyvitamin D and the CYP3A Biomarker 4β-Hydroxycholesterol in a High-Dose Vitamin D Supplementation Study. Drug Metabolism and Disposition. 41(4). 704–708. 14 indexed citations

Björkhem‐Bergman, Linda, Tobias Bäckström, Hanna Nylén, et al.. (2013). Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin. Drug Metabolism and Disposition. 41(8). 1488–1493. 65 indexed citations

Habtewold, Abiy, Wondwossen Amogne, Eyasu Makonnen, et al.. (2012). Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients. The Pharmacogenomics Journal. 13(6). 484–489. 41 indexed citations

10.

Nylén, Hanna, et al.. (2012). A comparison of 4β‐hydroxycholesterol : cholesterol and 6β‐hydroxycortisol : cortisol as markers of CYP3A4 induction. British Journal of Clinical Pharmacology. 75(6). 1536–1540. 40 indexed citations

11.

Nylén, Hanna, Lars Forsberg, Synnöve Lindemalm, et al.. (2011). Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol. European Journal of Clinical Pharmacology. 67(7). 715–722. 16 indexed citations

12.

Diczfalusy, Ulf, et al.. (2010). 4β‐hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans. British Journal of Clinical Pharmacology. 71(2). 183–189. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact